Literature DB >> 15085934

Total antioxidant levels are low during active TB and rise with anti-tuberculosis therapy.

I Wiid1, T Seaman, E G Hoal, A J S Benade, Paul D Van Helden.   

Abstract

In tuberculosis, oxidative stress is a result of tissue inflammation, poor dietary intake of micronutrients due to illness, free radical burst from activated macrophages, and anti-tuberculosis drugs. These free radicals may in turn contribute towards pulmonary inflammation if not neutralized by antioxidants. The total antioxidant status (TAS) of individuals is a function of dietary, enzymatic, and other systemic antioxidants and is therefore an indicator of the free radical load. Our aim was to evaluate the TAS of healthy and M. tuberculosis-infected persons from a high TB incidence community, as well as tuberculosis patients at various stages of antituberculosis drug treatment and to correlate results with plasma micronutrient levels. Blood plasma samples from TB infected patients and following antituberculosis drug treatment were assayed for TAS, vitamins A, E and Zinc. Statistical analysis of results was by one-way ANOVA and the Tukey multiple comparison post test. Active TB patients showed a significantly lower TAS (P < 0.001) compared to the community controls. We also show that TAS values increase during therapy. Results correlated with micronutrients vitamin A and zinc but vitamin E remained unaffected. We suggest that total antioxidant status of TB patients should be considered for more effective disease control and that diets low in antioxidants may render individuals susceptible to tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15085934     DOI: 10.1080/15216540410001671259

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  7 in total

1.  Dietary Intake of Antioxidant Vitamins and Carotenoids and Risk of Developing Active Tuberculosis in a Prospective Population-Based Cohort Study.

Authors:  Avril Z Soh; Cynthia B E Chee; Yee-Tang Wang; Jian-Min Yuan; Woon-Puay Koh
Journal:  Am J Epidemiol       Date:  2017-08-15       Impact factor: 4.897

2.  Effects of treatment on free radicals in patients with pulmonary tuberculosis in South Western Nigeria.

Authors:  Wasiu Olalekan Adebimpe; Ayodeji Oluwaseun Faremi; Sulaiman Adebayo Nassar
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

3.  Association between serum selenium level and conversion of bacteriological tests during antituberculosis treatment.

Authors:  Milena Lima de Moraes; Daniela Maria de Paula Ramalho; Karina Neves Delogo; Pryscila Fernandes Campino Miranda; Eliene Denites Duarte Mesquita; Hedi Marinho de Melo Guedes de Oliveira; Antônio Ruffino-Netto; Paulo César de Almeida; Rachel Ann Hauser-Davis; Reinaldo Calixto Campos; Afrânio Lineu Kritski; Martha Maria de Oliveira
Journal:  J Bras Pneumol       Date:  2014 May-Jun       Impact factor: 2.624

4.  Low plasma vitamin A concentration is associated with tuberculosis in Moroccan population: a preliminary case control study.

Authors:  Mounia Qrafli; Khalid El Kari; Hassan Aguenaou; Jamal Eddine Bourkadi; Khalid Sadki; Mohammed El Mzibri
Journal:  BMC Res Notes       Date:  2017-08-23

5.  Effects of zinc and vitamin A supplementation on prognostic markers and treatment outcomes of adults with pulmonary tuberculosis: a systematic review and meta-analysis.

Authors:  Fasil Wagnew; Kefyalew Addis Alene; Setegn Eshetie; Tom Wingfield; Matthew Kelly; Darren Gray
Journal:  BMJ Glob Health       Date:  2022-09

6.  Oxidative Stress in Wild Boars Naturally and Experimentally Infected with Mycobacterium bovis.

Authors:  Diana Gassó; Joaquín Vicente; Gregorio Mentaberre; Ramón Soriguer; Rocío Jiménez Rodríguez; Nora Navarro-González; Asta Tvarijonaviciute; Santiago Lavín; Pedro Fernández-Llario; Joaquim Segalés; Emmanuel Serrano
Journal:  PLoS One       Date:  2016-09-28       Impact factor: 3.240

7.  Serum paraoxonase 1 activity and oxidative stress in pediatric patients with pulmonary tuberculosis.

Authors:  Emel Torun; Ahmet Hakan Gedik; Erkan Cakir; Tarik Umutoglu; Ozlem Gok; Ulkan Kilic
Journal:  Med Princ Pract       Date:  2014-07-16       Impact factor: 1.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.